STATEMENTS OF OPERATIONS (Unaudited) - USD ($) $ in Thousands	3 Months Ended	6 Months Ended
Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023
Revenues [Abstract]
Total revenue	$ 5,177	$ 182	$ 9,003	$ 219
Operating expenses:
Selling, general and administrative	16,522	5,937	32,861	10,256
Research and development	3,319	5,725	8,267	8,464
Cost of product revenue	360	0	906	0
Cost of collaboration revenue	182	136	774	204
Total operating expenses	20,383	11,798	42,808	18,924
Loss from operations	(15,206)	(11,616)	(33,805)	(18,705)
Other (expense) income:
Interest income	393	626	991	1,126
Interest expense	(2,368)	0	(4,687)	0
Other expense	(5)	0	(16)	0
Total other (expense) income, net	(1,980)	626	(3,712)	1,126
Net loss	$ (17,186)	$ (10,990)	$ (37,517)	$ (17,579)
Net loss per share, basic	$ (0.37)	$ (0.24)	$ (0.81)	$ (0.4)
Net loss per share, diluted	$ (0.37)	$ (0.24)	$ (0.81)	$ (0.4)
Weighted-average common shares outstanding, basic	46,502,274	45,916,867	46,492,971	44,478,116
Weighted-average common shares outstanding, diluted	46,502,274	45,916,867	46,492,971	44,478,116
Product [Member]
Revenues [Abstract]
Total revenue	$ 4,892	$ 0	$ 8,124	$ 0
Collaboration [Member]
Revenues [Abstract]
Total revenue	$ 285	$ 182	$ 879	$ 219

The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.

Name:	us-gaap_EarningsPerShareBasic
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:perShareItemType
Balance Type:	na
Period Type:	duration

- Definition

The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.